278 related articles for article (PubMed ID: 32417942)
1. Modern management of splenomegaly in patients with myelofibrosis.
Tremblay D; Schwartz M; Bakst R; Patel R; Schiano T; Kremyanskaya M; Hoffman R; Mascarenhas J
Ann Hematol; 2020 Jul; 99(7):1441-1451. PubMed ID: 32417942
[TBL] [Abstract][Full Text] [Related]
2. Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
Sankar K; Pettit K
Curr Hematol Malig Rep; 2020 Oct; 15(5):391-400. PubMed ID: 32827272
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopically assisted splenectomy following preoperative splenic artery embolization using contour emboli for myelofibrosis with massive splenomegaly.
Iwase K; Higaki J; Mikata S; Tanaka Y; Yoshikawa M; Hori S; Osuga K; Kosugi S; Tamaki T; Kamiike W
Surg Laparosc Endosc Percutan Tech; 1999 Jun; 9(3):197-202. PubMed ID: 10804000
[TBL] [Abstract][Full Text] [Related]
4. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
[TBL] [Abstract][Full Text] [Related]
5. How I treat symptomatic splenomegaly in patients with myelofibrosis.
Mesa RA
Blood; 2009 May; 113(22):5394-400. PubMed ID: 19332765
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapeutic advances for splenomegaly in myelofibrosis.
Tremblay D; Mascarenhas J
Expert Opin Pharmacother; 2023 Apr; 24(5):577-585. PubMed ID: 36922391
[TBL] [Abstract][Full Text] [Related]
7. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
Elliott MA; Tefferi A
Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Myelofibrosis: A Moving Target.
Cerquozzi S; Farhadfar N; Tefferi A
Cancer J; 2016; 22(1):51-61. PubMed ID: 26841017
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis and Targeted Treatment Progress of Splenomegaly in Primary Myelofibrosis--Review].
Chen ZW; Wang SX; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):308-312. PubMed ID: 38387940
[TBL] [Abstract][Full Text] [Related]
10. [Laparoscopic splenectomy for a massive splenomegaly using a transcatheter technique].
Kobayashi S; Sekimoto M; Tomita N; Monden M
Nihon Geka Gakkai Zasshi; 1998 Oct; 99(10):733-6. PubMed ID: 9866840
[TBL] [Abstract][Full Text] [Related]
11. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia in Patients With Myelofibrosis: Pathogenesis, Prevalence, Prognostic Impact, and Treatment.
Sastow D; Mascarenhas J; Tremblay D
Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):e507-e520. PubMed ID: 35221248
[TBL] [Abstract][Full Text] [Related]
13. Management of challenging myelofibrosis after JAK inhibitor failure and/or progression.
Scherber RM; Mesa RA
Blood Rev; 2020 Jul; 42():100716. PubMed ID: 32593470
[TBL] [Abstract][Full Text] [Related]
14. Perioperative spleen embolization as a useful tool in laparoscopic splenectomy for simple and massive splenomegaly in children: a prospective study.
Van Der Veken E; Laureys M; Rodesch G; Steyaert H
Surg Endosc; 2016 Nov; 30(11):4962-4967. PubMed ID: 26961344
[TBL] [Abstract][Full Text] [Related]
15. Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.
Song MK; Park BB; Uhm JE
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562644
[TBL] [Abstract][Full Text] [Related]
16. How I manage anemia related to myelofibrosis and its treatment regimens.
Verstovsek S
Ann Hematol; 2023 Apr; 102(4):689-698. PubMed ID: 36786879
[TBL] [Abstract][Full Text] [Related]
17. Treatment and management of myelofibrosis in the era of JAK inhibitors.
Keohane C; Radia DH; Harrison CN
Biologics; 2013; 7():189-98. PubMed ID: 23990704
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal carcinomatosis-like implants of extramedullary hematopoiesis. An insolite occurrence during splenectomy for myelofibrosis.
Casaccia M; Fornaro R; Frascio M; Palombo D; Stabilini C; Firpo E; Gianetta E
Int J Surg Case Rep; 2017; 41():9-11. PubMed ID: 29024842
[TBL] [Abstract][Full Text] [Related]
19. Splenic artery embolization before laparoscopic splenectomy. An update.
Poulin EC; Mamazza J; Schlachta CM
Surg Endosc; 1998 Jun; 12(6):870-5. PubMed ID: 9602009
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications.
Malato A; Rossi E; Tiribelli M; Mendicino F; Pugliese N
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):588-595. PubMed ID: 32482540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
